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Abstract—We propose a new framework of computing-inspired
multifocal cancer detection procedure (MCDP). Under the rubric
of MCDP, the tumor foci to be detected are regarded as solutions
of the objective function, the tissue region around the cancer
areas represents the parameter space, and the nanorobots loaded
with contrast medium molecules for cancer detection correspond
to the optimization agents. The process that the nanorobots
detect tumors by swimming in the high-risk tissue region can
be regarded as the process that the agents search for the
solutions of an objective function in the parameter space with
some constraints. For multimodal optimization (MMO) aiming
to locate multiple optimal solutions in a single simulation run,
niche technology has been widely used. Specifically, the Niche
Genetic Algorithm (NGA) has been shown to be particularly
effective in solving MMO. It can be used to identify the global
optima of multiple hump functions in a running, keep effectively
the diversity of the population, and avoid premature of the
genetic algorithm. Learning from the optimization procedure
of NGA, we propose the NGA-inspired MCDP in order to
locate the tumor targets efficiently while taking into account
realistic in vivo propagation and controlling of nanorobots, which
is different from the use scenario of the standard NGA. To
improve the performance of the MCDP, we also modify the
crossover operator of the original NGA from crossing within
a population to crossing between two populations. Finally, we
present comprehensive numerical examples to demonstrate the
effectiveness of the NGA-inspired MCDP when the biological
objective function is associated with the blood flow velocity profile
caused by tumor-induced angiogenesis.
Index Terms—computing-inspired bio-detection, niche ge-
netic algorithm, multimodal optimization, cancer detection,
nanorobots, contrast-enhanced medical imaging.
I. INTRODUCTION
A. Background
Cancer refers to the abnormal and uncontrolled cell growth
due to an accumulation of specific genetic and epigenetic
defects [1]. It has been a leading cause of death globally for
many years [2]. As many cancers are diagnosed only after they
have metastasized throughout the body, effective and accurate
methods of early-stage cancer detection and clinical diagnosis
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are urgently needed [3]. Early detection of tissue malignancy
can increase greatly the chances for successful treatment and
it is particularly relevant for cancers of breast, cervix, mouth,
larynx, colon and rectum, and skin. For example, the five-
year survival rate is 90% if colorectal cancer is diagnosed
while still localized (i.e., confined to the wall of the bowel)
but reduces to only 68% for regional disease (i.e., disease with
lymph node involvement) and only 10% if distant metastases
are present [4]. The conventional imaging technology of cancer
detection such as ultrasound, computed tomography, positron
emission tomography, and magnetic resonance imaging (MRI)
have limitations in terms of tumor grading and molecular
characterization as they are not designed to image a small
number of cancer cells. Therefore, the conventional imaging
modalities are unpromising in early detection and localization
of cancer [5]–[7].
Nanoparticles are organic or inorganic, metallic, magnetic
or even polymeric particles with a diameter of less than 100
nm [8]. Nanoparticles exhibit several unique properties that
can be applied to develop chemical and biological sensors
possessing desirable features like enhanced sensitivity and
lower detection limits [9]. They can cross barriers such as
blood-brain barrier or gastrointestinal barrier, which is a major
advantage for the detection and visualization of tumor cells at
very early stages, ideally at the level of a single cell or multiple
cells [8]. For example, Liu et al. developed a nanosensor
that detected Carcinoembryonic Antigen as a model protein,
which showed potential applications for early diagnosis of
diseases [10]. Several studies have also been carried out on
early detection of tumor cells via the attachment of proteins ex-
pressed in very high quantity on cancer cells [11], [12]. These
novel nanoscale platforms possess excellent physiochemical
properties and offer prolonged circulation times and improved
absorption rates. However, these nanoparticles are circulated
systemically and thus exhibit poor targeting efficiency for
precise localization of the lesion [13], [14]. Enhancing the
diagnostic efficacy of nanoparticles necessitates the use of
guidance technologies, which demand effective controlling and
tracking of nanoparticles. This, in turn, calls for the integration
of sensing and actuation mechanisms at the nanoscale.
Recent decades have witnessed an enormous progress in
manipulation of nanorobots in the in vivo environment for
externally controllable early cancer detection [15]. Due to
their small size, however, individual nanorobots are limited in
their operational ranges and sensing capabilities. Nanorobots
must work together to cover large areas and perform com-
plex functionalities, which can be achieved through swarm
intelligence [15]–[17]. Furthermore, so far, very few groups
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have succeeded in developing a fully autonomous (i.e. with-
out the need for an external power source for propulsion)
nanorobot capable of effective thrust in practical applications.
To overcome these constraints, bio-inspired, biocompatible,
and biodegradable nanorobots such as flagellated magnetotac-
tic bacteria (MTB) with nanometer-sized magnetosomes have
been proposed [18], [19]. A swarm of MTB can be guided and
tracked by an external monitoring device such as a customized
MRI system to deliver drug-containing nanoliposomes to the
target areas, which can significantly improve the therapeutic
index of various nanocarriers in tumor regions as demonstrated
in [15]. However, to the best of our knowledge, there has
not been any experimental work in the existing literature on
applying nanorobots for effective early cancer detection. This
may be due to the fact that the destination is known a priori
in targeted drug delivery, which provides a clear direction for
generating the guiding field. On the other hand, the knowledge
of the location (or even presence) of tissue malignancy is
not available in early cancer detection, which significantly
increases the complexity of system design.
./ 
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Fig. 1: Pictorial illustration of the MCDP model
Recently, we have proposed a novel framework of
computing-inspired bio-detection, also called “Touchable
Computing” (TouchComp) [20], which attempts to shed some
theoretical insight on nanorobots-assisted, “smart” tumor sens-
ing. TouchComp extends the idea of swarm intelligence to
externally controllable biosensing, and improves the detection
efficiency compared to the random search strategy relying on
systemic circulation without making use of any intelligence
about the biological, chemical or physical phenomenon in-
duced by cancer cells [18], [21], [22]. The central idea of
TouchComp is summarized in Fig. 1. Consider the case of
a multifocal cancer detection procedure (MCDP). The tumor
foci are the regions-of-interest (ROIs) in a high-risk tissue re-
gion. The tumors trigger certain in vivo phenomena that can be
detected by observing the properties of a swarm of nanorobots
deployed due to the interaction between the nanorobots and the
environment. TouchComp aims to coordinate the movement of
all nanorobots through specific schemes of swarm intelligence
in order to search for the ROIs effectively.
B. Main Contributions of the Current Work
Different from our previous work, which focuses on the
detection of a single cancer [21], we look into the multimodal
bio-detection scenario (i.e., MCDP) in our present work.
Multifocal tumors are not multiple tumors; they originate from
a unique cellular clone and grow multifocally in a single organ
(liver, kidney, thyroid, etc.) [23]. As shown in Fig. 1, the
solutions are the tumor foci to be detected; the parameter space
representing all possible solutions is the tissue region at a high
risk of malignancy; the externally manoeuvrable agents are
nanorobots such as MTB. The agents (i.e., nanorobots) locate
all the optimal solutions (i.e., tumors) by moving through the
parameter space (i.e., high-risk tissue) under the guidance of
an exterior steering field (i.e., MRI).
Different from the classical mathematical computing that
uses ideal non-interacting agents, the landscape for the MCDP
that corresponds to a biological, chemical or physical cost
function induced by tumors may be altered by agents due to
the natural computing feature of MCDP, where agents interact
with the solution space (i.e., nanorobots undergo reactions in
the in vivo environment). An external observer can then infer
the landscape for cancer detection by monitoring the move-
ment of agents, which is called “seeing-is-sensing” in [19].
Provided with this analogy, a wide variety of computational
techniques can thus be applied to the design of optimal MCDP.
The genetic algorithm (GA) is a metaheuristic inspired by
the process of natural selection, which generates high-quality
solutions to optimization and search problems by relying
on bio-inspired operators such as mutation, crossover and
selection [24]. Niching methods allow the GA to maintain
a population of diverse individuals, which can be used in
domains that require the maintenance of multiple solutions
[25]. In this paper, the niche GA (NGA) is considered and
introduced into the MCDP with the assumption that the land-
scape of the tissue region under surveillance is nonlinear and
multimodal. Furthermore, we modify the crossover strategy
of the standard NGA by dividing the initial population into
two groups and implementing crossover between groups to
improve the performance of tumor detection.
This paper is organized as follows. In Section II, we
establish the foundation of computing-inspired MCDP by
transforming the problem into an optimization procedure.
In particular, we employ externally controllable nanorobots
moving in the blood vessels to indicate the blood flow velocity
that cannot be imaged by conventional imaging techniques
because of their low resolutions [5]–[7], [18]. A multiple hump
function with three global minima is employed to represent the
distribution of blood flow velocity in the presence of cancerous
tissues as described in [26]–[28]. In Section III, we propose the
NGA-inspired MCDP following the problem setting presented
in Section II and modify the normal NGA from the algorithmic
perspective. In Section IV, some numerical examples are
provided to demonstrate the principles and effectiveness of
the proposed framework. Finally, some conclusive remarks are
drawn in Section V.
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II. COMPUTING-INSPIRED MCDP
The framework of computing-inspired bio-detection builds
upon the similarity between the evolutionary computational
process and the nanorobots-assisted MCDP. An evolution-
ary system can be seen as a process that, given particular
initial conditions, follows a trajectory over time through a
complex evolutionary state space to develop problem solvers
automatically [24]. The swarm of nanorobots can be seen
as an evolutionary system with the aim to accomplish bio-
detection in an efficient and robust manner. More specifically,
an aggregation of nanorobots loaded with contrast medium
molecules are injected into the high-risk tissue, which corre-
sponds to the initialization step of the evolutionary system.
The nanorobots swim in the in vivo environment following
certain trajectories to search for the tumors and the process is
monitored by an external macro-scale device. To evaluate the
chance of finding tumors by nanorobots at specific locations,
the concept of “fitness function” in mathematics and computer
science is introduced. As the existing experimental results
show that the velocity of blood flow in which nanorobots
exist usually increases with the distance from a cancer as
to be elaborated further in Section II-B, the “fitness” of a
nanorobot is negatively correlated with the blood flow veloc-
ity it experiences. Subsequently, the nanorobots update their
locations in the tissue region under surveillance according to
their fitness values. When a tumor is detected by a nanorobot,
the nanorobot will adhere to the tumor and appears to stop
moving (i.e., its velocity observed by the external monitoring
system reduces to zero). It is worth noting that the reduc-
tion of blood flow velocity alone does not necessarily mean
that there is a tumor; only a complete stop of a nanorobot
indicates the presence and location of a tumor. Subsequently,
the nanorobots-assisted MCDP can be formulated as a stylized
representation of the general problem of agents-aided solution-
searching in the parameter space [21].
A. Problem Formulation
Consider a general parameter space P with the following
agent-dependent landscape [21]:
o
(®x; A) = oms (®x; A) + of it (®x; A)
= oin
(®x) + oex (®x; A) + of it (®x; A) , ®x ∈ P, (1)
where oms
(®x; A) is the externally measurable objective func-
tion at location ®x for agent A, oin
(®x) is the intrinsic objective
function at ®x independent of the presence or absence of A,
oex
(®x; A) is the extrinsic disturbance to the landscape caused
by the interaction between A and the parameter space P,
and of it
(®x; A) is the correction factor accounting for the
activeness of A, due to its degradation in P. The computing-
inspired model of MCDP can be expressed as follows: given
a search space (i.e., high-risk tissue) P, the agents move
through the search space to locate the targets (i.e., tumors).
It is assumed that the tumor locations remain unchanged
regardless of any variation caused by agents to the landscape.
Nanorobots can bind to tumor cell receptors when they detect
the tumors and stop moving, indicating termination of the
MCDP. Furthermore, we use the velocity of blood flow as
the objective function to define the fitness of nanorobots.
Subsequently, the MCDP can be seen as a procedure to search
for the minimum values of the objective function:
min
®x∈P
o
(®x; A) (2)
In the MCDP, an optimization or niching method aims to
locate all possible ®x∗ ∈ P (i.e., identifying all the tumors),
which result in the smallest possible objective values:
o
(®x∗; A) ≤ o (®x; A) , ∀®x ∈ P . (3)
The mapped o values in the immediate vicinity of an ®x∗
should be all equal or higher than o
(®x∗; A) . The corresponding
solution set is denoted as S.
More specifically, N nanorobotic agents A1, A2, · · · , AN are
injected into the capillary around the high-risk tissue as shown
in Fig. 1. The agents are employed to search for the solution
set S, with their initial locations ®x1(t0), ®x2(t0), · · · , ®xN (t0) at
the initial time t0. The initial speed of An (n = 1, 2, ..., N) is
vn(®xn(t0)), which is assumed to be equal to the blood flow
velocity at ®xn(t0), as blood has a low Reynolds coefficient and
the inertia force of agents can be ignored compared to the
viscosity force [29]. The location of agent An can be updated
according to Eq. (4) as the capillary network of the healthy
tissue is grid-like [21]:
®xn(tk+1) = ®xn(tk) + dn(tk, tk+1)®u∠φF ( ®xn(tk ))+φP ( ®xn(tk ))
= ®xn(tk) +
Ln(tk,tk+1)∑
l=1
vn(®xn(tk))δtn,l(tk, tk+1)
× ®u∠φn, l (tk,tk+1).
(4)
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Fig. 2: Update of the location of agent An in one iteration
As illustrated in Fig. 2, when An does not meet the target,
it will move continuously from ®xn(tk) at time tk to ®xn(tk+1)
at time tk+1 in one iteration. The path of the nanorobot is
composed of some linear segments. The term dn(tk, tk+1) in
(4) is the displacement length of An from ®xn(tk) to ®xn(tk+1),
Ln(tk, tk+1) is the number of piecewise-linear sections along
the trajectory of An from ®xn(tk) to ®xn(tk+1) in the search space;
the traveling time of the l th linear section is δtn,l(tk, tk+1) that
satisfies
∑Ln(tk,tk+1)
l=1 δtn,l(tk, tk+1) = tk+1 − tk = 4t, where 4t
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is the iteration period of the external steering field; ®u∠φ is
a unit vector with angle φ. The objective functions obtained
by all agents are computed according to (1). When An meets
the solution set S (i.e., a tumor is detected by a nanorobot),
the stopping criteria are met. Otherwise, An will continue to
move according to (4). A new agent will be randomly deployed
within the injected area to ensure a constant number of agents
in the medium, if an old agent fully degenerates [18].
B. Landscape of Parameter Space
The blood flow rate in a vascular network is proportional
to the pressure difference between the arterial and venous
sides and inversely proportional to the viscous and geometric
resistances. Microvascular pressures in the arterial side are
nearly equal in tumor and nontumorous vessels. Pressures in
venular vessels are significantly lower in a tumor than those
in a nontumorous tissue [30]. The presence of tumors can thus
affect the distribution of blood flow velocity in the capillaries
of the high-risk tissue. The blood flow velocity was shown to
decrease significantly when blood enters the tumors (dropping
from 183.4 ± 35.0µm/s to 114.1 ± 26.1µm/s) and then soon
return to the prior level upon flowing out of the tumors
[31]. Furthermore, the blood flow near malignant tumors has
been studied using radioactive 90Y microspheres while treating
patients. The qualitative investigation demonstrates a normal
tissue flow/tumor flow ratio in the range of 3/1 to 30/1. In
addition, the peripheral tumor areas show a higher flow rate
than more central portions [27], [32].
Based on the aforementioned phenomena, we consider a
representative artificial landscape to evaluate the performance
of MCDP, which synthesizes the scenario of the blood flow
variation around the tumor foci and can be regarded as the
biological cost function to be optimized. In other words, the
landscape shown in Fig. 3 can be used to represent f (®x) =
o(®x;A)(mm/s), where ®x = (x, y) is in mm and the parameter
range is 0 ≤ x, y ≤ 10mm.
As shown in Fig. 3, the landscape with three different
humps represents the situation that there are three tumor foci.
The blood flow velocity decreases with the distance from the
centers of the three tumors, (5.1, 7.3), (4.4, 5.9) and (5, 2.8)
respectively. The objective function is expressed as follows
[33].
f
(®x) =

0,
√
(x − 5.1)2 + (y − 7.3)2 ≤ 0.1√3
0,
√
(x − 4.4)2 + (y − 5.9)2 ≤ 0.1√4
0,
√
(x − 5)2 + (y − 2.8)2 ≤ 0.1√5
−  f1 (®x) + f2 (®x) + f3 (®x)  + 0.18, Otherwise
(5)
where,
f1
(®x) = (6 − x)2 exp [− (x − 5)2 − (y − 6)2] (6)
f2
(®x) = −0.1 [x/5 − (x − 5)3 − (y − 5)5 − 1]2
× exp [− (x − 5)2 − (y − 5)2] (7)
f3
(®x) = 0.5exp [− (x − 4)2 − (y − 5)2] (8)
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Fig. 3: (a) Three-dimensional plot of the artificial landscape, and (b) blood velocity
contour of the parameter space.
C. Capillary Network Model of Tumors
In tumor vasculature, the large surface areas of capillaries
make them the ideal site to provide nutrients and oxygen for
the growing of tumors [34]. For tumors, angiogenesis appears
to be a critical determinant of growth, invasion, and metastatic
potential [35]–[37]. The angiogenic activity is located within a
few hundred micrometers from the tumor rim. Fueling further
growth, the resulting neovasculature is progressively coopted
together with the original blood vessels by the expanding
tumor mass while also pushing the neovascularization zone
further into normal tissue [38]. The hastily formed new tumor
microcirculation is always different from the host vasculature
due to the influence of tumor angiogenesis factors and re-
duction of the available oxygen and nutrients [30], [39]–[41].
Hence tumors are known to contain many tortuous vessels,
shunts, vascular loops, widely variable intervascular distances,
and large avascular areas, while normal capillaries are almost
uniformly distributed to ensure adequate oxygen and nutri-
ents transportation through the tissue [42]. The microvascular
density is greater in the periphery of the highly vascularized
tumor than that of the surrounding normal tissue [43]. These
characteristics of tumor vasculature are well synthesized by
the invasion percolation method, which is a classical statistical
growth process governed by local substrate properties [44].
The simulation of vascular growth begins with a square
lattice of discrete points that represents potential paths of
vascular growth. Invasion percolation is implemented by first
assigning uniformly distributed random values or strengths to
each point on the underlying lattice. Starting at an arbitrary
point the network occupies the lattice point adjacent to the
current network that has the lowest strength. Growth is iterated
until the desired lattice occupancy is reached. Blood vessels
are assumed to connect all adjacent occupied lattice points.
Blood is supplied at the starting point and withdrawn from
the point nearest to the opposite corner. The network is
then pruned to retain only those parts of the network with
nonzero flow, leaving what is known as the “backbone” of
the percolation cluster. Fig. 4 depicts the invasion percolation
result after 260 growth steps, which also shows the backbone
of the percolation clusters after pruning the vessels with zero
blood flow.
It is a common strategy to restrict the vessels to run only
parallel to the coordinate axes in modeling microvasculature
[40], [43], [45], [46]. Subsequently, it is appropriate to model
the tumor capillary network using the latticed model with a
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Fig. 4: Computer-generated percolation network after 260 growth steps of occupancy
after pruning of vessels with zero blood flow.
fixed microvascular density for normal tissues and a greater
microvascular density for the periphery of tumors. In this way,
we simulate the tumor-induced angiogenesis for the blood flow
velocity profile in (5) as shown in Fig. 5. The global capillary
network is a square with an area of 10mm× 10mm. There are
three different tumor foci T1, T2, and T3, which are repre-
sented by three different square areas. The center coordinates
of the tumors are (5.1, 7.3), (4.4, 5.9), (5, 2.8) and the side
lengthes are 0.8mm, 1mm, 1.2mm, respectively. The centers
of the tumor foci where the velocity of nanorobots becomes
zero are three circular areas with a radius of 100µm. We
define the intercapillary distances to be 100µm for the normal
capillary network and 50µm for capillaries in the periphery
of the tumors. The periphery we define here corresponds to
the blood velocity contour with the value of 60µm/s. The
level of occupancy on the lattice is chosen to be 60% before
pruning [44]. For each vascular element in Fig. 5, the flow
rate is assumed to follow the Poiseuille’s law. A number of
capillary elements come together at each node, which satisfies
mass conservation and therefore the sum of all flows at each
node is zero. The general direction of blood flow is from the
bottom left coordinate (0, 0) to the top right coordinate (10,
10), which is 45◦ to the x and y axes, respectively as shown
in Fig. 5.
III. NGA-INSPIRED MCDP
The GA firstly proposed and analyzed by J. H. Holland
in 1975 is commonly used to solve optimization problems
[24], [47], [48]. As an effective method for solving complex
problems, once the genetic representation and the fitness func-
tion are defined, a GA proceeds to initialize a population of
solutions and then to improve it through repetitive application
of the mutation, crossover, inversion and selection operators
[49].
However, traditional GAs will push an artificial population
towards convergence though natural evolutionary processes
maintain a variety of species with each occupying a
separate ecological niche. In nature, a niche is viewed as
an organism’s task in the environment, and a species is a
collection of organisms with similar features. The subdivision
of environment on the basis of an organism’s role helps
stable subpopulations to form around different niches in
Fig. 5: Simulated vascular network for the blood flow velocity profile in (5). The
vasculature is created by regular space-filling arrays with different microvascular densities
representing normal and peritumoral tissues and invasion-percolation-based structure
representing tumor tissues with a reduced microvascular density. The tumor foci centers
are denoted by the red circles.
the environment [50]. Niching technique has recently been
introduced into GAs to make it possible to find more than one
local optimum of a multimodal landscape. Niching technology
can make individuals evolve in a special environment by
adjusting the fitness of individuals and the replacement
strategy to generate the new generation. This method can
maintain diversity of evolution population and acquire
multiple solutions at the same time. Three general niching
techniques: pre-selection, crowding, and fitness sharing are
popular. The NGA is widely used in the multimodal and
non-monotonic function optimization. In NGA, a niche is
commonly referred to as the location of each optimum in the
search space, and the fitness represents the resource of that
niche. The organisms in a niche can be defined as similar
individuals in terms of similarity metrics. The pseudo code
of NGA is given in Algorithm 1.
As for the selection operator, we use the method of roulette
wheel selection, which is the first selection method developed
by Holland [44]. The probability of selection for each indi-
vidual i, Pi , is defined by:
Pi =
Fi∑N
j=1 Fj
(9)
where Fi is equal to the fitness of individual i. As for the
crossover operator, we use traditional two-parent crossover
operator and characterize the result of this process using real-
value coding. The N individuals are paired at random, yielding
N/2 couples. For each couple, crossover may or may not
occur. Crossover does not occur with the probability of 1− pc .
Subsequently, both individuals proceed to the mutation stage.
Otherwise, the couple generates two children via crossover,
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Algorithm 1 NGA
1: Choose an initial population A1, A2, · · · , AN with their
initial locations ®x01 , ®x02 , · · · , ®x0N
2: Evaluate fitness of agents A1, A2, · · · , AN .
3: for k less than the initialized iteration number K do
4: Use normal genetic operators to get new positions
®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)N of new agents
5: Replace the old agents (positions ®xk1 , ®xk2 , · · · , ®xkN ) with
new agents (positions ®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)N )
6: Use niching technology in agents:
7: while Distance(®x(k+1)i , ®x(k+1)j ) ≤ L do
8: Penalize the worse agent
9: end while
10: Evaluate fitness of agents (the initial population of next
generation) at positions ®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)N
11: end for
and only the children continue to the mutation stage. The
crossover and mutation processes are as follows:{
®x(k+1)n = α ®xkn + (1 − α)®xkn+1
®x(k+1)
n+1 = α ®xkn+1 + (1 − α)®xkn
(10)
®x(k+1)n = ®xkn + σ (11)
where α follows a uniform distribution between 0 and 1 (i.e.
α ∼ U(0, 1)), and σ follows a Gaussian distribution with
mean 0 and variance 1 (i.e. σ ∼ N(0, 1)). Then, we use a
niching method with modified crowding scheme to preserve
population diversity. In crowding, each individual is compared
to its neighbor within a constant distance, and the worse one
is punished with a less opportunity to produce an offspring.
Inspired by the physiological viewpoint that offspring resulting
from inbreeding tends to be unhealthy, we further propose
a modified NGA. In the algorithm, the initial population is
separated into two groups with the same number of individuals
randomly; each individual in one group can only perform
crossover with an arbitrary individual in another group; the
rest of the processes are similar with the original NGA. The
modified NGA is represented in the pseudo code of Algorithm
2.
In the following, we will formulate the MCDP based on
the similar evolutionary mechanism with the aforementioned
NGAs but taking into account realistic in vivo propagation,
controlling, and tracking scenarios.
Nanorobots loaded with contrast medium molecules are in-
jected into the tissue region. The injection area is a 1mm×1mm
square as shown in Fig. 5. Each nanorobot adjusts its own
location based on the comparison with its offspring location
under the influence of the blood flow and the external magnetic
field. Fig. 6 gives the movement direction of agent An in
MCDP. The location of An at step k is denoted by the
vector ®xkn ; the ideal child location of An following the NGA
is denoted by the vector ®x(k+1)n and the actual location of
An following the MCDP is denoted by the vector ®xk+1n ;
The blood velocity, the nanorobot’s velocity subject to the
Algorithm 2 Modified NGA
1: Choose two initial populations A1, A2, · · · , AM and
AM+1, AM+2, · · · , AN with their initial locations ®x01 , ®x02 ,· · · , ®x0M and ®x0M+1, ®x0M+2, · · · , ®x0N
2: Evaluate fitness of agents A1, A2, · · · , AN .
3: for k less than the initialized iteration number K do
4: Use normal genetic operators with crossover between
two groups to get new positions ®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)M
and ®x(k+1)
M+1 , ®x(k+1)M+2 , · · · , ®x(k+1)N of new agents.
5: Replace the old agents (positions ®xk1 , ®xk2 , · · · , ®xkM and
®xk
M+1, ®xkM+2, · · · , ®xkN ) with new agents (positions ®x(k+1)1 ,
®x(k+1)2 , · · · , ®x(k+1)M and ®x(k+1)M+1 , ®x(k+1)M+2 , · · · , ®x(k+1)N ).
6: Use niching technology in agents:
7: while Distance(®x(k+1)i , ®x(k+1)j ) ≤ L do
8: Penalize the worse agent
9: end while
10: Evaluate fitness of agents (the initial population of next
generation) at positions ®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)N
11: end for
magnetic field without the influence of blood flow, and their
resultant velocity are denoted by ®vb , ®vm, and ®vc , respectively.
Subsequently, agent An will move by one step in the direction
of ®vc and the new position of An denoted by ®xk+1n will
be obtained. ®xk+1n then plays the role of parent in the next
generation. Following this process, each nanorobot updates its
location step by step. Note that the capillary network of healthy
tissue and the tumor capillary network used in the simulation
procedure are discontinuous two-dimensional grids; therefore,
all agents’ locations are mapped to the locations associated
with the nearest blood vessel.
Subsequently, agent An evolves according to the following
equations:
®u∠φ( ®xkn ) =
®x(k+1)n − ®xkn
| ®x(k+1)n − ®xkn |
(12)
®xk+1n = ®xkn +
Ln∑
l=1
vnδtn,l ®u∠φn, l (13)
The index n = 1, 2, · · · , N; φ(®xn) denotes the angle gener-
ated by the co-force of the external magnetic field and the
blood flow on agent An at ®xkn , φn,l is the direction of the l th
linear section, ®u∠φ is a unit vector with angle φ, Ln is the
number of piecewise-linear sections along the trajectory of
the nth agent in one iteration and δtn,l is the traveling time
of the l th linear section satisfying
∑Ln
l=1 δtn,l = ∆t with ∆t
being the constant interval of the controlling cycle. Eq. (12)
is used to calculate the new movement direction of the agent
An by taking into the agent’s current position and its offspring
position obtained by the NGA operators. Eq. (13) is used to
evaluate the updated position of the agent An given the steering
field and the underlying vascular network.
From the description above, we can see that the ideal
location of each new agent provides a direction for the
movement of its parent nanorobot. Every parent nanorobot
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Fig. 6: Update of the location of a nanorobot: (a) the angle between the directions of
the blood flow and the magnetic field is acute; and (b) the angle between the directions
of the blood flow and the magnetic field is obtuse.
swims in the direction of its offspring agent under the steering
of the external magnetic field and the blood flow field. The
key difference between the NGA-inspired MCDP proposed
here and the NGA presented previously is the offspring used.
For NGA, the offsprings can be at any random locations in
the continuous searching space, while the offsprings produced
in the MCDP are all in the locations of blood vessels as the
nanorobots can only swim in the capillary network. The NGA-
inspired MCDP is described in Algorithm 3.
Algorithm 3 MCDP Algorithm
1: Choose an initial population A1, A2, · · · , AN with their
initial locations ®x01 , ®x02 , · · · , ®x0N
2: Evaluate fitness of agents A1, A2, · · · , AN .
3: for k less than the initialized iteration number K do
4: Use normal genetic operators to get new positions
®x(k+1)1 , ®x(k+1)2 , · · · , ®x(k+1)N of new agents
5: while the agents stopping criterion not met do
6: Move agents towards the offspring locations ®x(k+1)1 ,
®x(k+1)2 , · · · , ®x(k+1)N with the same steps respectively and get
the new positions of agents ®xk+11 , ®xk+12 , · · · , ®xk+1N
7: end while
8: Use niche technology in agents:
9: while Distance(®xk+1i , ®xk+1j ) ≤ L do
10: Penalize the worse agent
11: end while
12: Evaluate fitness of agents (the initial population of next
generation) at positions ®xk+11 , ®xk+12 , · · · , ®xk+1N .
13: end for
The initial deployment region of all the agents (i.e., the
injected area shown in Fig. 5) is confined within a small area
due to the practical constraint of the NGA-inspired MCDP,
which is different from the normal NGA where all the agents
are distributed in the whole searching space in the initial stage.
All the nanorobots swim in the high-risk tissue under the
external magnetic field to detect tumor areas using the MCDP
given above. In case any nanorobot travels outside the search
space, a new nanorobot will be deployed in the initial area
to keep the number of nanorobots unchanged. The escaped
nanorobot will degrade in the human body without causing
any harmful effect [21].
Inspired by the modified NGA, we introduce the new
crossover scheme into MCDP. In this scenario, the nanorobots
employed are divided into two groups randomly chosen in
the initial phase with the other processes being similar to the
aforementioned MCDP algorithm.
IV. PERFORMANCE ANALYSIS
We use several numerical examples to elaborate on the
NGA-inspired MCDP. The blood flow velocity profile pre-
sented in Section II-B and the vascular network model pre-
sented in Section II-C are applied to synthesize tumor an-
giogenesis. In the simulation, 12 nanorobots are employed to
execute the MCDP. The small number of nanorobots is chosen
to minimize any side effect resulting from an excessive amount
of nanorobots on the human body. The initial injection area
is 0 ≤ x, y ≤ 1mm as shown in Fig. 5. The initial speed of
nanorobots is assumed to be 210µm/s, which can be realized
according to [18]. The period of iteration is set to be 4s and the
number of iterations is 60. The probabilities of crossover and
mutation are 0.9 and 0.1, respectively. The crowding distance
is set to be 0.15mm.
Fig. 7 shows a typical curve of minimum outcomes obtained
from the agents over multiple iterations for the blood velocity
profile in (5) by using the NGA-inspired MCDP. It can be
seen that an agent with the best performance can detect a
tumor successfully at the 22th iteration. To compare with
the cancer detection method relying on systemic circulation
without applying any metaheuristics under the same physical
scenario, we also present the result obtained from the random
searching strategy, which means the nanorobots swim in the
capillary network without any external influence except the
blood flow. In this case, we can see that the best agent can
detect a tumor after 41 iterations, which is slower compared to
the NGA-inspired MCDP. Furthermore, for comparison from
the algorithmic perspective, we show the result for the standard
NGA without any physical constraints. In this case, a target
can be detected after 4 iterations.
Fig. 8 shows the final locations of agents after 60 iterations
by using the three different algorithms. We can see that
the agents in the NGA and MCDP algorithms have a good
performance of clustering with nearly all the agents swarming
around the different target areas. On the contrary, the agents
in the random searching strategy are scattered in the searching
space without any swarming behavior.
To provide statistical analysis of robustness and precision
of the NGA-inspired MCDP, we have carried out 500 in-
dependent simulation runs. Fig. 9(a), (b), and (c) show the
histograms of the quantity of agents located at the targets using
the MCDP, random searching and normal NGA strategies
with the means of 1.54, 0.07 and 3.85, and the variances
of 1.68, 0.08 and 1.79, respectively. It is evident that the
proposed MCDP significantly outperforms random searching
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in term of the number of agents that can detect the cancer foci
successfully. The performance of the MCDP strategy is not as
good as the standard NGA, which is due to the fact that the
MCDP is subject to various physical constraints.
Fig. 10 shows the curves of minimum outcomes obtained
from the agents over multiple iterations by using the modified
NGA, random searching and MCDP algorithms. Comparing
Fig. 10 to Fig. 7, it can be seen that the MCDP inspired by the
modified NGA performs worse than the one derived from the
standard NGA in terms of the time spent in detecting a single
tumor because of the decrease in exploitation for the modified
NGA. On the other hand, the other comparison results between
the three methods are similar with the earlier observations.
Fig. 11 shows the final locations of agents after 60 iterations
in the second case. It can be seen that the result in Fig. 11 is
similar with that in Fig. 8.
Fig. 12 gives the histogram of the quantity of agents located
at the tumor foci using the three algorithms in the second case.
Though the observations made in Fig. 12 are somewhat similar
with those from Fig. 9, it is interesting to note that the mean
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Fig. 9: (a) Histogram of the quantity of agents located at the tumor areas using MCDP
strategy. (b) Histogram of the quantity of agents located at the tumor areas using random
searching strategy. (c) Histogram of the quantity of agents located at the target areas
using normal NGA.
0.2 
-MCDP 
-- NGA 
－…Random 
…··． 
. ... � 、＇ n ， ， ． ． ．  ‘＿； i ” · ． ．  
i I I • • • 
i I I ． ． ． 
i I I ．． ． h ” ．． ． －， ， ．． ． －， ， ．． ． h” ·· ． 1” ．． ． 坷 ’
善 ’
． 
． ’ 
． ． 
l
i
s
－－’’’’
’ 
i
t
’
st
s
s
t
－
－
－ 
‘ ．． ，
1 
份言 0.15
E 
Cl) 
E 。。.... 
:::i 。
E 
:::i 
E 
丢 0.05
0.1 
60 50 40 30 
Iteration 
20 10 
。。
Fig. 10: Minimum outcomes obtained over iterations.
10 
⑤Contour 
QMCDP 
* Random 
口 NGA
t寻
* 
8 
4 
2 
6 ｛EE王
10 8 6 
x(mm) 
4 2 
。。
Fig. 11: Final positions of agents in the searching space.
DRAFT PAPER FOR IEEE TRANSACTIONS ON CYBERNETICS 9
in the second case for MCDP is 2.40, which is greater than
the value of 1.54 in Fig. 9(a) due to the increase in exploration
for the modified NGA.
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Fig. 12: (a) Histogram of the quantity of agents located at the tumor areas using MCDP
strategy. (b) Histogram of the quantity of agents located at the tumor areas using random
searching strategy. (c) Histogram of the quantity of agents located at the target areas
using modified NGA
Fig. 13: The distribution of nanorobots at three different tumor areas T1- (a, d), T2- (b,
e), T3- (c, f) using two different MCDP strategies.
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Fig. 14: The distribution of nanorobots at three different tumor areas T1- (a), T2- (b),
T3- (c) using random searching strategy.
Fig. 13 presents the histograms of the quantity of nanorobots
located at the three different tumors using the two different
MCDP strategies. Fig. 13(a), (b) and (c) show the distribution
of nanorobots located at the tumor foci T1, T2, and T3 re-
spectively by using the MCDP inspired by the standard NGA.
Fig. 13(d), (e), and (f) show the distribution of nanorobots
located at tumor foci T1, T2, and T3 respectively by using
the MCDP inspired by the modified NGA. It is evident that
for both the two strategies, the numbers of nanorobots in T1,
T2, and T3 are increasing, which is in line with the sizes
of the tumors T1<T2<T3. For comparison, we also give the
distribution of nanorobots located at the tumor areas T1, T2,
and T3 respectively by using the random searching strategy,
which is shown in Fig. 14. It is interesting to see that the
numbers of nanorobots in T1, T2, and T3 are not adaptable to
the tumors’ area ratio. This is mainly caused by the relative
orientations of the three tumors. For example, tumor T1 can be
barely detected by any nanorobot under the random searching
strategy because it is shadowed by tumor T2 without any line-
of-sight to the injected area.
In summary, we can draw the conclusion that the MCDP
performs better than random searching. Furthermore, the
MCDP inspired by the modified NGA performs better than
that inspired by the normal NGA.
V. CONCLUSION
We have presented the nanorobots-assisted detection of
multifocal cancer from a multimodal optimization perspective.
Specifically, we have proposed the NGA-inspired MCDP by
taking into account realistic in vivo conditions of nanorobots
and characteristics of vascular network around the tumor areas.
Based on this work, we have also developed a modified NGA,
which can be used to improve the performance of MCDP.
Numerical examples have demonstrated the effectiveness of
the proposed methodology for the blood flow velocity profile
induced by tumor angiogenesis.
Future work may include improving the performance of the
algorithm to accomplish the detection of all the cancer areas
with many more nanorobots. It is also important to examine
further the impact of nanorobot nonidealities, such as finite
lifespan, imprecise steering, and inaccurate tracking.
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